Sunshine Biopharma Inc
SBFM
查看详细走势图
1.310USD
0.000
收盘 12/24, 13:00（美东）报价延迟15分钟
5.97M总市值
0.25市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
0.00%
5天
-5.76%
1月
-5.76%
6月
-12.08%
今年开始到现在
-56.33%
1年
-59.57%
查看详细走势图
TradingKey Sunshine Biopharma Inc股票评分
单位: USD 更新时间: 2025-12-24操作建议
Sunshine Biopharma Inc当前公司基本面数据相对非常健康，增长潜力很大。当前估值合理，在药品行业排名105/158位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价6.00。中期看，股价处于下降通道。近一个月，市场表现较差，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Sunshine Biopharma Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
1
位分析师
买入
评级
6.000
目标均价
+313.79%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Sunshine Biopharma Inc亮点
亮点风险
Sunshine Biopharma Inc. is a pharmaceutical company engaged in offering and researching life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for the treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The Company operates two wholly owned subsidiaries: Nora Pharma Inc., which has a portfolio of pharmaceutical products consisting of various prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells nonprescription over-the-counter (OTC) products.
业绩高增长
公司营业收入稳步增长，连续3年增长702.52%
业绩增长期
公司处于发展阶段，最新年度总收入34.87M美元
估值高估
公司最新PE估值0.25，处于3年历史高位
机构减仓
最新机构持股128.14K股，环比减少68.34%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓，最新持仓市值55.70K
Sunshine Biopharma Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Sunshine Biopharma Inc简介
Sunshine Biopharma Inc. is a pharmaceutical company engaged in offering and researching life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for the treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The Company operates two wholly owned subsidiaries: Nora Pharma Inc., which has a portfolio of pharmaceutical products consisting of various prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells nonprescription over-the-counter (OTC) products.
公司代码SBFM
公司Sunshine Biopharma Inc
CEOSlilaty (Steve N)
网址https://www.sunshinebiopharma.com/
常见问题
Sunshine Biopharma Inc(SBFM)的当前股价是多少？
Sunshine Biopharma Inc(SBFM)的当前股价是 1.310。
Sunshine Biopharma Inc的股票代码是什么？
Sunshine Biopharma Inc的股票代码是SBFM。
Sunshine Biopharma Inc股票的52周最高点是多少？
Sunshine Biopharma Inc股票的52周最高点是3.900。
Sunshine Biopharma Inc股票的52周最低点是多少？
Sunshine Biopharma Inc股票的52周最低点是1.169。
Sunshine Biopharma Inc的市值是多少？
Sunshine Biopharma Inc的市值是5.97M。
Sunshine Biopharma Inc的净利润是多少？
Sunshine Biopharma Inc的净利润为-5.13M。
现在Sunshine Biopharma Inc(SBFM)的股票是买入、持有还是卖出？
根据分析师评级，Sunshine Biopharma Inc(SBFM)的总体评级为买入，目标价格为6.000。
Sunshine Biopharma Inc(SBFM)股票的每股收益（EPS TTM）是多少
Sunshine Biopharma Inc(SBFM)股票的每股收益（EPS TTM）是5.318。
相关品种
